| Style | Citing Format |
|---|---|
| MLA | Sharifian H, et al.. "Genetic Diversity and Chromosomal Variations in the Iranian Leishmania Major Strain: Insights Into Pathogenicity and Drug Resistance." Advanced Biomedical Research, vol. 14, no. 1, 2025, pp. -. |
| APA | Sharifian H, Khalafiyan A, Fadaie M, Khanahmad H, Shahmoradi Z, Zaker E, Mousavi P, Pourmoshir N, Zolfaghari A (2025). Genetic Diversity and Chromosomal Variations in the Iranian Leishmania Major Strain: Insights Into Pathogenicity and Drug Resistance. Advanced Biomedical Research, 14(1), -. |
| Chicago | Sharifian H, Khalafiyan A, Fadaie M, Khanahmad H, Shahmoradi Z, Zaker E, Mousavi P, Pourmoshir N, Zolfaghari A. "Genetic Diversity and Chromosomal Variations in the Iranian Leishmania Major Strain: Insights Into Pathogenicity and Drug Resistance." Advanced Biomedical Research 14, no. 1 (2025): -. |
| Harvard | Sharifian H et al. (2025) 'Genetic Diversity and Chromosomal Variations in the Iranian Leishmania Major Strain: Insights Into Pathogenicity and Drug Resistance', Advanced Biomedical Research, 14(1), pp. -. |
| Vancouver | Sharifian H, Khalafiyan A, Fadaie M, Khanahmad H, Shahmoradi Z, Zaker E, et al.. Genetic Diversity and Chromosomal Variations in the Iranian Leishmania Major Strain: Insights Into Pathogenicity and Drug Resistance. Advanced Biomedical Research. 2025;14(1):-. |
| BibTex | @article{ author = {Sharifian H and Khalafiyan A and Fadaie M and Khanahmad H and Shahmoradi Z and Zaker E and Mousavi P and Pourmoshir N and Zolfaghari A}, title = {Genetic Diversity and Chromosomal Variations in the Iranian Leishmania Major Strain: Insights Into Pathogenicity and Drug Resistance}, journal = {Advanced Biomedical Research}, volume = {14}, number = {1}, pages = {-}, year = {2025} } |
| RIS | TY - JOUR AU - Sharifian H AU - Khalafiyan A AU - Fadaie M AU - Khanahmad H AU - Shahmoradi Z AU - Zaker E AU - Mousavi P AU - Pourmoshir N AU - Zolfaghari A TI - Genetic Diversity and Chromosomal Variations in the Iranian Leishmania Major Strain: Insights Into Pathogenicity and Drug Resistance JO - Advanced Biomedical Research VL - 14 IS - 1 SP - EP - PY - 2025 ER - |